Mapping Tool Reveals Cocoa May Reverse Age-Related Memory Decline
|
By LabMedica International staff writers Posted on 05 Nov 2014 |

Image: This fMRI scan shows the brain area outlined in yellow is the hippocampus; the dentate gyrus is shown in green and the entorhinal cortex in purple. Previous work, including by the laboratory of senior author Scott A. Small, M.D., had shown that changes in a specific part of the brain’s hippocampus--the dentate gyrus--are associated with normal age-related memory decline in humans and other mammals. The dentate gyrus is distinct from the entorhinal cortex, the hippocampal region affected in early-stage Alzheimer’s disease (Photo courtesy of the Laboratory of Scott A. Small, MD).

Image: The dentate gyrus is distinct from the entorhinal cortex, the hippocampal region affected in early-stage Alzheimer’s disease. Previous work, including by the laboratory of senior author Scott A. Small, MD, had shown that changes in a specific part of the brain’s hippocampus—the dentate gyrus—are associated with normal age-related memory decline in humans and other mammals (Photo courtesy of Columbia University Medical Center).
Dietary cocoa flavanols, naturally occurring bioactives found in cocoa, has been shown to reverse age-related memory decline in healthy older adults, according to new findings. Flavanols are also found naturally in tea leaves and in specific fruits and vegetables.
The research was led by Columbia University Medical Center (CUMC; New York, NY, USA) scientists, and their findings were published October 26, 2014, in the advance online issue of the journal Nature Neuroscience. The study provides the first direct evidence that one component of age-related memory decline in humans is caused by changes in a specific region of the brain and that this form of memory decline can be improved by a dietary intervention.
As individuals get older, they typically show some decline in cognitive abilities, including learning and remembering such things as the names of new acquaintances or where one placed one’s wallet. This normal age-related memory decline begins in early adulthood but typically does not have any noticeable impact on quality of life until people reach their fifties or sixties. Age-related memory decline is different from the frequently-debilitating memory impairment that occurs with Alzheimer’s, in which a disease process damages and destroys neurons in various parts of the brain, including the memory circuits.
Earlier research, including by the laboratory of senior author Scott A. Small, MD, had shown that changes in a specific region of the brain—the dentate gyrus—are associated with age-related memory decline. Up to now, however, the evidence in humans showed only a correlational association, not a causal one. To see if the dentate gyrus is the source of age-related memory decline in humans, Dr. Small and his colleagues assessed whether compounds called cocoa flavanols can enhance the function of this brain region and improve memory. Flavanols extracted from cocoa beans had earlier been found to improve neuronal connections in the dentate gyrus of mice. Dr. Small is a professor of neurology in the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, the Sergievsky Center, and the departments of radiology and psychiatry, and director of the Alzheimer’s Disease Research Center in the Taub Institute at CUMC.
A cocoa flavanol-containing test drink prepared specifically for research purposes was produced by the food company Mars, Inc. (McLean, VA, USA), which also partly supported the research, using a proprietary process to extract flavanols from cocoa beans. Most methods of processing cocoa remove many of the flavanols found in the raw plant.
In the CUMC study, 37 healthy volunteers, ages 50 to 69, were randomized to receive either a high-flavanol diet (900 mg of flavanols a day) or a low-flavanol diet (10 mg of flavanols a day) for three months. Brain imaging and memory tests were administered to each participant before and after the study. Functional magnetic resonance imaging (fMRI) brain imaging scans were used to measure blood volume in the dentate gyrus, a gauge of metabolism, and the memory test involved a 20-minute pattern-recognition exercise designed to evaluate a type of memory controlled by the dentate gyrus.
“When we imaged our research subjects’ brains, we found noticeable improvements in the function of the dentate gyrus in those who consumed the high-cocoa-flavanol drink” said lead author Adam M. Brickman, PhD, associate professor of neuropsychology at the Taub Institute.
The high-flavanol group also performed considerably better on the memory test. “If a participant had the memory of a typical 60-year-old at the beginning of the study, after three months that person on average had the memory of a typical 30- or 40-year-old,” said Dr. Small. He cautioned, however, that the findings need to be replicated in a larger study, which he and his team plan to do.
Flavanols are also found naturally in tea leaves and in specific fruits and vegetables, but the overall amounts, as well as the specific forms and mixtures, vary widely. The precise formulation used in the CUMC study has also been shown to enhance cardiovascular health. Brigham and Women’s Hospital (Boston, MA, USA) announced a US National Institutes of Health (NIH; Bethesda, MD, USA)-funded study of 18,000 men and women to see whether flavanols can help prevent heart attacks and strokes. The researchers cautioned, however, that the product used in the study is not the same as chocolate, and they warn against an increase in chocolate consumption in an attempt to gain this effect.
Two advanced technologies used by the investigators made the study possible. A high-resolution variant of fMRI scanning was used to map the precise site of age-related DG dysfunction and to develop a cognitive task whose function localized to this anatomic site. The new data-processing tool allows the imaging data to be presented in a single, three-dimensional image instead of in numerous individual slices. The application was developed in Dr. Small’s lab by Usman A. Khan, an MD-PhD student in the lab, and Frank A. Provenzano, a biomedical engineering graduate student at Columbia. The other innovation was a modification to a classic neuropsychologic test, allowing the researchers to evaluate memory function specifically localized to the dentate gyrus. The revised test was developed by Drs. Brickman and Small.
Exercise, in addition to flavanols, has been shown in previous studies, including those of Dr. Small, to improve memory and dentate gyrus function in younger people. In the current study, the researchers were unable to assess whether exercise had an effect on memory or on dentate gyrus activity. “Since we didn’t reach the intended VO2max [maximal oxygen uptake] target, we couldn’t evaluate whether exercise was beneficial in this context. This is not to saythat exercise is not beneficial for cognition. It may be that older people need more intense exercise to reach VO2max levels that have therapeutic effects,” concluded Dr. Small,
Related Links:
Columbia University Medical Center
The research was led by Columbia University Medical Center (CUMC; New York, NY, USA) scientists, and their findings were published October 26, 2014, in the advance online issue of the journal Nature Neuroscience. The study provides the first direct evidence that one component of age-related memory decline in humans is caused by changes in a specific region of the brain and that this form of memory decline can be improved by a dietary intervention.
As individuals get older, they typically show some decline in cognitive abilities, including learning and remembering such things as the names of new acquaintances or where one placed one’s wallet. This normal age-related memory decline begins in early adulthood but typically does not have any noticeable impact on quality of life until people reach their fifties or sixties. Age-related memory decline is different from the frequently-debilitating memory impairment that occurs with Alzheimer’s, in which a disease process damages and destroys neurons in various parts of the brain, including the memory circuits.
Earlier research, including by the laboratory of senior author Scott A. Small, MD, had shown that changes in a specific region of the brain—the dentate gyrus—are associated with age-related memory decline. Up to now, however, the evidence in humans showed only a correlational association, not a causal one. To see if the dentate gyrus is the source of age-related memory decline in humans, Dr. Small and his colleagues assessed whether compounds called cocoa flavanols can enhance the function of this brain region and improve memory. Flavanols extracted from cocoa beans had earlier been found to improve neuronal connections in the dentate gyrus of mice. Dr. Small is a professor of neurology in the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, the Sergievsky Center, and the departments of radiology and psychiatry, and director of the Alzheimer’s Disease Research Center in the Taub Institute at CUMC.
A cocoa flavanol-containing test drink prepared specifically for research purposes was produced by the food company Mars, Inc. (McLean, VA, USA), which also partly supported the research, using a proprietary process to extract flavanols from cocoa beans. Most methods of processing cocoa remove many of the flavanols found in the raw plant.
In the CUMC study, 37 healthy volunteers, ages 50 to 69, were randomized to receive either a high-flavanol diet (900 mg of flavanols a day) or a low-flavanol diet (10 mg of flavanols a day) for three months. Brain imaging and memory tests were administered to each participant before and after the study. Functional magnetic resonance imaging (fMRI) brain imaging scans were used to measure blood volume in the dentate gyrus, a gauge of metabolism, and the memory test involved a 20-minute pattern-recognition exercise designed to evaluate a type of memory controlled by the dentate gyrus.
“When we imaged our research subjects’ brains, we found noticeable improvements in the function of the dentate gyrus in those who consumed the high-cocoa-flavanol drink” said lead author Adam M. Brickman, PhD, associate professor of neuropsychology at the Taub Institute.
The high-flavanol group also performed considerably better on the memory test. “If a participant had the memory of a typical 60-year-old at the beginning of the study, after three months that person on average had the memory of a typical 30- or 40-year-old,” said Dr. Small. He cautioned, however, that the findings need to be replicated in a larger study, which he and his team plan to do.
Flavanols are also found naturally in tea leaves and in specific fruits and vegetables, but the overall amounts, as well as the specific forms and mixtures, vary widely. The precise formulation used in the CUMC study has also been shown to enhance cardiovascular health. Brigham and Women’s Hospital (Boston, MA, USA) announced a US National Institutes of Health (NIH; Bethesda, MD, USA)-funded study of 18,000 men and women to see whether flavanols can help prevent heart attacks and strokes. The researchers cautioned, however, that the product used in the study is not the same as chocolate, and they warn against an increase in chocolate consumption in an attempt to gain this effect.
Two advanced technologies used by the investigators made the study possible. A high-resolution variant of fMRI scanning was used to map the precise site of age-related DG dysfunction and to develop a cognitive task whose function localized to this anatomic site. The new data-processing tool allows the imaging data to be presented in a single, three-dimensional image instead of in numerous individual slices. The application was developed in Dr. Small’s lab by Usman A. Khan, an MD-PhD student in the lab, and Frank A. Provenzano, a biomedical engineering graduate student at Columbia. The other innovation was a modification to a classic neuropsychologic test, allowing the researchers to evaluate memory function specifically localized to the dentate gyrus. The revised test was developed by Drs. Brickman and Small.
Exercise, in addition to flavanols, has been shown in previous studies, including those of Dr. Small, to improve memory and dentate gyrus function in younger people. In the current study, the researchers were unable to assess whether exercise had an effect on memory or on dentate gyrus activity. “Since we didn’t reach the intended VO2max [maximal oxygen uptake] target, we couldn’t evaluate whether exercise was beneficial in this context. This is not to saythat exercise is not beneficial for cognition. It may be that older people need more intense exercise to reach VO2max levels that have therapeutic effects,” concluded Dr. Small,
Related Links:
Columbia University Medical Center
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







